CPN1 and obesity due to melanocortin 4 receptor deficiency: In this study, we employed an integrated strategy that combined network pharmacology, quantitative transcriptomics, molecular docking, and experimental validation, to screen and unveil the key targets and pathways of Cpn in alleviating obesity in mice.